Neutralizing antibodies to toxin: what they are
Quick facts
- Definition
- Antibodies that block the action of botulinum toxin in the body.
- Consequence
- A reduced or absent response to treatment, known as secondary resistance.
- Cited factors
- High doses, short intervals and frequent touch-ups.
- Frequency
- Described as uncommon in aesthetic indications.
- Approach
- Assess the cause of the lost response before increasing the dose.
Neutralizing antibodies are immune system proteins that bind to botulinum toxin and block its effect. When they form, the patient responds little or not at all to treatment, a condition called secondary resistance.
How is resistance explained?
The toxin is a protein, and the body can recognize it as foreign. The formulation includes, besides the active toxin, the protein complex, and the debate over which part triggers the immune response is a long one. The serotypes used also matter: switching products does not always solve the problem.
Which factors are usually cited?
- High doses in each session.
- Short intervals between applications.
- Frequent touch-ups, which add up to more exposure.
- Prolonged use over many years.
In aesthetics, doses are low and the phenomenon is described as uncommon, but not impossible. It is not appropriate to label a loss of effect as "resistance" before other explanations have been considered.
What about the "rebound effect"?
Loss of response and the rebound effect are different ideas. Rebound describes the impression that the muscle came back stronger, and it does not depend on antibodies.
What should the professional do?
Record the product, dose and dates in the patient record, advise the patient about intervals, and avoid unnecessary touch-ups. The decision to continue, switch products or stop belongs to the licensed professional, in line with the rules of their professional council (in Brazil, the council for their profession).
Also called: immune resistance to toxin, secondary failure.
Frequently asked questions
Why did the toxin stop working for some patients?
There are several possible causes: insufficient dose, technique, improperly stored product or, more rarely, neutralizing antibodies. This last cause is only considered after the others have been ruled out.